Dendrobine inhibits dopaminergic neuron apoptosis via MANF-mediated ER stress suppression in MPTP/MPP+-induced Parkinson's disease models

Phytomedicine. 2022 Jul 20:102:154193. doi: 10.1016/j.phymed.2022.154193. Epub 2022 May 22.

Abstract

Background: Parkinson's disease (PD) is an age-related neurodegenerative disorder without effective treatments. Mesencephalic astrocyte-derived neurotrophic factor (MANF) has been suggested to be capable of protecting against PD by inhibiting endoplasmic reticulum (ER) stress-mediated neuronal apoptosis.

Purpose: This study was aimed to evaluate the antiparkinsonian effect of dendrobine and reveal its underlying mechanisms from the perspective of MANF-mediated ER stress suppression.

Methods: Behavioral assessments of PD mice as well as LDH/CCK-8 assay in SH-SY5Y cells and primary midbrain neurons were carried out to detect the antiparkinsonian effect of dendrobine. Immunofluorescence, western blot, flow cytometry and shRNA-mediated MANF knockdown were used to determine the apoptosis of dopaminergic neurons and the expressions of ER stress-related proteins for investigating the underlying mechanism of dendrobine.

Results: Dendrobine significantly ameliorated the motor performance of PD mice and attenuated the injuries of dopaminergic neurons. Dendrobine could also relieve neuronal apoptosis, up-regulate MANF expression and inhibit ER stress, which were largely abolished by shRNA-mediated MANF knockdown in PD model.

Conclusion: Dendrobine might protect against PD by inhibiting dopaminergic neuron apoptosis, which was achieved by facilitating MANF-mediated ER stress suppression. Our study suggested that dendrobine could act as a MANF up-regulator to protect against PD, and provided a potential candidate for exploring etiological agents of PD.

Keywords: Dendrobine; Dopaminergic neuron; ER stress; MANF; Parkinson's disease.

MeSH terms

  • Alkaloids* / pharmacology
  • Animals
  • Antiparkinson Agents / pharmacology
  • Apoptosis / drug effects
  • Dopamine / metabolism
  • Dopaminergic Neurons* / drug effects
  • Dopaminergic Neurons* / pathology
  • Endoplasmic Reticulum Stress* / drug effects
  • Humans
  • Mice
  • Nerve Growth Factors / metabolism
  • Neuroblastoma / metabolism
  • Neuroblastoma / pathology
  • Parkinson Disease* / drug therapy
  • Parkinson Disease* / metabolism
  • Parkinson Disease* / pathology
  • RNA, Small Interfering / pharmacology

Substances

  • Alkaloids
  • Antiparkinson Agents
  • MANF protein, human
  • MANF protein, mouse
  • Nerve Growth Factors
  • RNA, Small Interfering
  • dendrobine
  • Dopamine